Skip to main content
Premium Trial:

Request an Annual Quote

'Nutraceutical' Shop Wellgen Pockets $9.5M in VC Cash for Staff Expansion, Other Needs

NEW YORK (GenomeWeb News) - WellGen has taken in $9.5 million in a Series C round of venture-capital financing from new and existing shareholders, the company said Monday.
 
The nutrigenomics company said it plans to use the cash to hire new personnel and expand its "molecular biology and natural products chemistry laboratory."
 
It also plans to develop an anti-obesity ingredient used in foods and conduct further studies of WG0401, an enriched extract from black tea that the company said has "demonstrated inflammation-fighting properties in multiple studies in humans."